Cushings Syndrome Market Clinical Review and Demands In Healthcare Industry 2018-2026
Cushing’s
syndrome is a collection of symptoms and signs, which includes high
blood pressure, reddish stretch marks, abdominal obesity, round red
face, weak muscles, weak bones, a fat lump between the shoulders and
fragile skin that heals slowly due to prolonged exposure to cortisol.
Excessive cortisol-like medication such as prednisone or tumor that
is produced due to excess cortisol by adrenal glands are the two
basic factors that cause Cushing’s syndrome. Other tumors may also
cause this disease, which are associated with inherited disorders
such as multiple endocrine neoplasia type 1 and Carney complex. Most
cases can be treated and cured by combination of surgery radiation or
chemotherapy.
The
key players dominating the global Cushing’s syndrome market
Increase
in research and development in 2016, which includes development of
clinical trials for RECORLEV for the treatment of endogenous
Cushing’s syndrome by Strongbrigde Biopharma plc is expected to
create competition and also favor the growth between various
manufacture to lead the market. The key players operating in
Cushing’s syndrome market include Corcept Therapeutics Inc., HRA
Pharma, Strongbridge Biopharma plc. and Novartis AG.
Download
the PDF brochure:
https://www.coherentmarketinsights.com/insight/request-pdf/554
The
most significant cause of Cushing’s syndrome is intake of
glucocorticoids prescribed by a healthcare professional to cure other
diseases such as asthma, rheumatoid arthritis or in immunosuppression
after an organ transplant. Administration of synthetic ACTH can also
lead to the condition. It may also occur in other animals such as
cats, dogs, and horse. All the factors mentioned above are expected
to favor the growth of Cushing’s syndrome market.
Cushing’s
syndrome Market Taxonomy
By
Drug Type
By
End User
Rise
in cortisol hormone fuels the growth of Cushing’s syndrome market
Hormonal
disorder caused due to prolonged exposure of body’s tissue to high
levels of hormone cortisol leads to Cushing’s syndrome, also called
hypercortisolism. Adults aged in the age group of 20-50 years suffer
from Cushing’s syndrome. It is rarely seen, though has risk of
development in patient who are obese and also have type 2 diabetes,
high blood pressure with poorly controlled blood glucose.
Regional
growth engines that supports Cushing’s syndrome market
In
terms of geography Cushing’s syndrome is segmented into North
America, Europe, Asia-pacific, Middle East, Latin America and Africa.
Due to presence of high income standard and health awareness in North
America favors the growth of Cushing’s syndrome market.
Click To Read More On Cushings
Syndrome Market
About
Us:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Comments
Post a Comment